About Jay Lichter
Jay Lichter is a director at Enlaza Therapeutics.
Form D filings also name Jay Lichter as a director at AristaMD.
Jay Lichter reports to the SEC as a director, officer or major shareholder of 5 public companies, including Janux Therapeutics (JANX), Otonomy (OTIC) and Synthorx (THOR).
Jay Lichter first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Jay Lichter in the role, so the role may have started earlier or lasted longer.
JI
Janux Therapeutics, Inc.
Director and 10% owner
2021 – 2024 · Public company (JANX)
OI
Otonomy, Inc.
Director and 10% owner
2014 – 2022 · Public company (OTIC)
SI
Synthorx, Inc.
Director and 10% owner
2018 – 2020 · Public company (THOR)
AI
Aratana Therapeutics, Inc.
Director and 10% owner
2013 – 2015 · Public company (PETX)
AI
Akesis Pharmaceuticals, Inc.
President and CEO, director
2006 – 2008 · Public company (AKES.OB)
Key Colleagues at Startups
The people Jay Lichter works with at each company, as listed on that company's latest Form D.
Enlaza Therapeutics, Inc. · Form D, Sep 11, 2025
MM
Marcos Milla
Director
SS
Stephen Squinto
Director
TR
Tighe Reardon
Executive officer
SC
Shelley Chu
Director
SD
Sergio Duron
Chief Executive Officer and director
JT
James Topper
Director
SM
Sanford Madigan
Executive officer
AristaMD, Inc. · Form D, Feb 28, 2020
TC
Thomas Cooper
Director
MS
Michael Scarbrough
Director
TR
Tighe Reardon
Executive officer and director
BL
Brooke LeVasseur
CEO and director